Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CASR | P41180 | 6/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL580177 | 0.86 | NR2E1 (0.48) | MEN1KMT2ANPC1CASRMAPT | |
| SCHEMBL5558959 | 0.86 | PLA2G4B (0.38) | MEN1KMT2AMAPTSMN1; SMN2CYP1A2 | |
| SCHEMBL7607965 | 0.83 | PLA2G4B (0.36) | KMT2AMAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL277377 | 0.82 | MAPT (0.43) | MEN1KMT2ANPC1CASRMAPT | |
| SCHEMBL4656279 | 0.82 | KMT2A (0.40) | MEN1KMT2ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL4554162 | 0.80 | TDP1 (0.41) | MEN1KMT2ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL7887570 | 0.80 | MAPT (0.43) | NPC1MAPTSMN1; SMN2POLBCYP1A2 | |
| SCHEMBL30996060 | 0.80 | NR2E1 (0.46) | MEN1KMT2ANPC1CASRMAPT | |
| SCHEMBL5163603 | 0.79 | KMT2A (0.40) | MEN1KMT2ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL15127483 | 0.78 | CASR (0.42) | MEN1KMT2ANPC1CASRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007110415-A2 | USE OF DIACETYL TRIMERS AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING THESE COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2007-10-04 | — | — | WO | claimed |
| US-20240237643-A1 | COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY | SYMRISE AG (DE) | 2024-07-18 | — | — | US | disclosed |
| US-20240216248-A1 | MICROBIAL GLYCOLIPIDS | ANALYTICON DISCOVERY GMBH (DE) | 2024-07-04 | — | — | US | disclosed |
| US-12023396-B2 | Flavour and fragrance compositions comprising acetophenone derivatives | SYMRISE AG (DE) | 2024-07-02 | — | — | US | disclosed |
| US-12016944-B2 | Mixtures comprising a protein extract for the treatment of human skin and/or hair | SYMRISE AG (DE) | 2024-06-25 | — | — | US | disclosed |
| CN-118141701-A | Composition containing benzoic acid derivative or furoic acid derivative and use of the derivative for emulsion and foam stability | 西姆莱斯股份公司 | 2024-06-07 | — | — | CN | disclosed |
| EP-4373462-A1 | COMPOSITIONS OF DICAFFEOYLQUINIC ACIDS WITH TOCOPHEROL | Symrise AG (DE) | 2024-05-29 | — | — | EP | disclosed |
| US-20240122816-A1 | ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN | SYMRISE AG (DE) | 2024-04-18 | — | — | US | disclosed |
| US-20240122834-A1 | MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION | SYMRISE AG (DE) | 2024-04-18 | — | — | US | disclosed |
| US-11938208-B2 | Antimicrobial mixture | SYMRISE AG (DE) | 2024-03-26 | — | — | US | disclosed |
| US-20050249688-A1 | Hair care composition | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2005-11-10 | — | — | US | disclosed |
| EP-1326955-B1 | MULTI-PHASE SOAP | SYMRISE GMBH & CO KG (DE) | 2004-12-22 | — | — | EP | disclosed |
| EP-1341752-B1 | NOVEL INDANYLIDENE COMPOUNDS | SYMRISE GMBH & CO KG (DE) | 2004-08-04 | — | — | EP | disclosed |
| US-6673756-B2 | MULTILAYER; CUTTING, JOINING UNDER PRESSURE | SYMRISE GMBH & CO. KG (DE) | 2004-01-06 | — | — | US | disclosed |
| WO-2003092643-A1 | LIGHT-PROTECTION FORMULATIONS USING ACRYLONITRILE DERIVATIVES | SYMRISE GMBH & CO. KG (DE) | 2003-11-13 | — | — | WO | disclosed |
| WO-2003084496-A1 | LIGHT-PROTECTIVE PREPARATIONS CONTAINING A PHOTOSTABLE UV-A FILTER | SYMRISE GMBH & CO. KG (DE) | 2003-10-16 | — | — | WO | disclosed |
| EP-1326955-A1 | MULTI-PHASE SOAP | HAARMANN & REIMER GMBH (DE) | 2003-07-16 | — | — | EP | disclosed |
| US-20020173436-A1 | Multilayer; cutting, joining under pressure | SYMRISE GMBH & CO. KG (DE) | 2002-11-21 | — | — | US | disclosed |
| US-20020143203-A1 | Novel indanylidene compounds | SYMRISE GMBH & CO. KG (DE) | 2002-10-03 | — | — | US | disclosed |
| WO-2002024857-A1 | MULTI-PHASE SOAP | HAARMANN & REIMER GMBH (DE) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12023396-B2 | Flavour and fragrance compositions comprising acetophenone derivatives | FAAH2, ADH5, NISCH | MEN1 3838/4885KMT2A 3181/4885NPC1 1744/4885 |
| US-20240122834-A1 | MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION | MC1R, OR51E2, TYR | MEN1 3943/4885KMT2A 4263/4885NPC1 1473/4885 |
| US-20050249688-A1 | Hair care composition | KRT18, CUTA, LAGE3 | MEN1 1970/4885KMT2A 584/4885NPC1 4465/4885 |
| US-20020143203-A1 | Novel indanylidene compounds | CUTA, NISCH, ERCC4 | MEN1 2511/4885KMT2A 3196/4885NPC1 1907/4885 |
| US-20240216248-A1 | MICROBIAL GLYCOLIPIDS | UGCG, SGMS1, GPR119 | MEN1 2789/4885KMT2A 2648/4885NPC1 1000/4885 |
| US-20240122816-A1 | ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN | CUTA, POLR1C, SLC16A7 | MEN1 2879/4885KMT2A 679/4885NPC1 1614/4885 |
| US-11938208-B2 | Antimicrobial mixture | GNPAT, GMDS, DDOST | MEN1 4312/4885KMT2A 4755/4885NPC1 1559/4885 |
| US-20240237643-A1 | COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY | ZC3HAV1, SAMHD1, ZC3HAV1L | MEN1 4207/4885KMT2A 3922/4885NPC1 1214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.